Originating in ancient India, Ayurveda is an alternative medicinal approach that provides substantial evidence for a theoretical-level analysis of all aspects of life. Unlike modern medicine, Ayurveda is based upon tridoshas (Vata, pitta, and Kapha) and Prakriti. On the other hand, the research of all the genes involved at the proteomics, metabolomics, and transcriptome levels are referred to as genomics. Geoclimatic regions (deshanupatini), familial characteristics (kulanupatini), and ethnicity (jatiprasakta) have all been shown to affect phenotypic variability. The combination of genomics with Ayurveda known as ayurgenomics provided new insights into tridosha that may pave the way for precision medicine (personalized medicine). Through successful coordination of “omics,” Prakriti-based treatments can help change the existing situation in health care. Prakriti refers to an individual’s behavioral trait, which is established at the moment of birth and cannot be fully altered during one’s existence. Ayurvedic methodologies are based on three Prakriti aspects: aushadhi (medication), vihara (lifestyle), and ahara (diet). A foundation of Prakriti-based medicine, preventative medicine, and improvement of life quality with longevity can be accomplished through these ayurvedic characteristics. In this perspective, we try to understand prakriti’s use in personalized medicine, and how to integrate it with programs for drug development and discovery.

No abstract

The current study aims to explore and identify the screening of formulation components and evaluates the quality issues of nanostructured lipid carriers (NLCs) for the phenolic secoirodoid Oleuropein. The stepwise screening of the components for preparation of NLCs includes the selection of solid lipid, liquid lipid based on the relative solubility of Oleuropein in different lipids. Polaxomer 188 was selected as the main surfactant for the preparation of NLCs because of its good emulsification efficacy for the solid lipid liquid mix. Lecithin was used to enhance the stability of NLC. The optimized formulation was also evaluated for different quality issues. Thermal analysis by DSC revealed that the lipid particles maintained sufficiently good melting point even after nanonization. Absence of gelation and resilience for the stress provided by autoclaving further established the quality of the developed NLCs. In a nutshell, a systematic protocol was developed for designing of Oleuropein NLC with good particulate parameters of minimum particle size and maximum zeta potential with narrow polydispersity index.

Skin ageing is due to the combination of natural, largely genetically programmed and environmentally modulated changes which occur in the body system due to free radical damage. Silver Nanoparticle (AgNPs), were prepared by chemical reduction using green synthesis and they were evaluated for particle size in nanometer, zeta potential in millivolt, surface morphology by scanning electron microscopy (SEM) and percent entrapment efficiency. The polyphenols were quantified by chromatographic techniques and the antioxidant activity measured spectrophotometrically by DPPH (2,2 Diphenyl 1 picrylhydrazyl) assay. According to this study AgNPs showed a least particle size of 145.4±2.4nm, maximum zeta potential of -39.1±2.4 mV with desired polydispersity index of 0.358±0.02, the amount of polyphenols loaded in AgNPs was found to be 87.23±2.54%. Maximum phenolic content was found in F1 as 65.21 ± 3.721 mg equivalent GAE/g of extract. On comparing the IC50  values, F1 and F5 exhibited the lowest and highest values respectively. Therefore, F1 possesses higher DPPH radical scavenging potential.

Many drugs are available in the market for several diseases, disorder or even for a condition, but it is difficult to select a suitable carrier to attain maximum bioavailability and potential for a potent drug. Attaining a controlled and sustained release of a drug is purely focused on the selection of a carrier (natural, synthetic and hybrid) like nanosomes. Nanosomes have become a prominent tool in the field of pharmacy. Nanosomes are small uniform structures which deliver the drug to the specific targeted site, which mainly depends upon the presence of ligands, shape, size and surface chemistry. Nanosomes are available in various types which include Niosomes, Liposomes, Electrosomes, Aquasomes, Transfersomes, Phytosomes, Enzymosomes, Ethosomes, Invasome and Sphingosomes. In general, all these nanosomes are quite similar in nature with minute differences in their vesicular characteristics and composition. This review traces various ‘somes’ composition and their role in the formulation, applications, advantages, disadvantages, common formulation procedures and evaluation parameters.